on M1 Kliniken AG (ETR:DE000A0S)
M1 Kliniken AG Reports 35.5% Rise in Nine-Month Beauty EBIT
M1 Kliniken AG has announced a 35.5% increase in its nine-month Beauty EBIT, reaching EUR 28.6 million, surpassing its entire 2025 total. The EBIT margin expanded to 33.0% from 27.1% in the previous year.
The third quarter saw significant growth with earnings climbing 63.9% to EUR 10.0 million. This comes alongside a revenue increase of 11.7%, totaling EUR 29.7 million in Q3 2026.
Despite group revenue declines due to the sale of HAEMATO Pharm GmbH, adjusted EBIT still rose by 21.1%. M1 Kliniken is realigning its focus solely on the Beauty segment after exiting the Trading segment.
Looking forward, the company aims to achieve revenue between EUR 200 million and EUR 300 million by 2029. Expansion plans include increasing its clinic network in Germany and globally, accompanied by a move to the Prime Standard of the Frankfurt Stock Exchange in 2027.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all M1 Kliniken AG news